Replies to post #6341 on Sesen Bio Inc (SESN)

[RumplePigSkin]

Thanks for the response. Given the full float with the latest approved share issuance of ~3$ (even though they’re priced at ~.001 if I remember correctly) making the float at ~200 M (175 M & 25 M @ 3$).

Is the FDA approval priced into the SP? Or will this drug post an FDA approval start to tap into the 3 billion $ market of bladder cancer where ~83% of that market is the non-muscle form?

Anyone have any theories on valuation post a successful FDA approval in a yr and 2 yrs?

With a biotech industry PE being between 25 and 40, do folks here believe this company could generate 50, 100, 250, 500 million a yr from the 3 billion $ market?

Thanks in advance.